C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/70 (2006.01) A61K 38/00 (2006.01) A61K 38/39 (2006.01) A61K 39/395 (2006.01) A61K 49/00 (2006.01) C07H 21/04 (2006.01) C12N 15/09 (2006.01) C12N 15/12 (2006.01) C12N 15/16 (2006.01) G01N 33/564 (2006.01) C07K 16/18 (2006.01)
Patent
CA 2159957
The present invention refers to the novel use of osteopontin, calnexin and TSG-6gene product in the diagnosis, prophylaxis or therapy of IL-1.beta. mediated diseases of connective tissues and to novel genes induced or repressed by stimulation of chondrocytes with IL-1.beta. and their use in the diagnosis, prophylaxis or therapy of IL- 1.beta. mediated diseases of connective tissues.
Bartnik Eckart
Margerie Daniel
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
LandOfFree
Regulated genes by stimulation of chondrocytes with il-1.beta. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulated genes by stimulation of chondrocytes with il-1.beta., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulated genes by stimulation of chondrocytes with il-1.beta. will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1483380